The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.45
Bid: 94.05
Ask: 94.20
Change: 1.10 (1.18%)
Spread: 0.15 (0.159%)
Open: 93.40
High: 95.65
Low: 93.40
Prev. Close: 93.35
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement

13 Mar 2019 16:06

RNS Number : 7936S
Primary Health Properties PLC
13 March 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

13 March 2019

Rule 2.9 Announcement

Primary Health Properties PLC (the "Company")

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), the Company confirms that, as at the date of this announcement, it has 790,189,579 ordinary shares of 12.5p each in issue and admitted to trading on the London Stock Exchange. The International Securities Identification Number for the Company's ordinary shares is GB00BYRJ5J14 and the LEI number is 213800Y5CJHXOATK7X11.

In addition, the Company has £3,700,000 nominal outstanding of the £82,500,000 4.25% Guaranteed Convertible Bonds 2019 (the "Convertible Bonds") issued by the Company's wholly owned subsidiary PHP Finance (Jersey) Limited ("PHP Jersey") and which were guaranteed by the Company. The Convertible Bonds are each convertible into fully paid ordinary shares of 12.5 pence each in the capital of the Company and would result in up to an additional 3,847,754 shares being issued if converting at the price of 96.16 pence. The International Securities Identification Number for the Convertible Bonds is XS1067950615.

For further information:

Primary Health Properties PLC

Paul Wright, Company Secretary

 

+44 (0)20 7451 7050

 

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at http://www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RTTUORNRKOAOAAR
Date   Source Headline
19th Jun 20233:26 pmRNSDirector/PDMR Shareholding
19th Jun 20233:23 pmRNSDirector/PDMR Shareholding
14th Jun 20239:26 amRNSHolding(s) in Company
22nd May 20239:47 amRNSDirector/PDMR Shareholding
15th May 20239:18 amRNSDirector/PDMR Shareholding
26th Apr 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20233:58 pmRNSDirector/PDMR Shareholding
19th Apr 20233:23 pmRNSAGM Statement
19th Apr 20237:00 amRNSQ1 2023 Trading Update
11th Apr 20232:46 pmRNSDirector/PDMR Shareholding
11th Apr 20232:44 pmRNSDirector/PDMR Shareholding
6th Apr 202311:14 amRNSDirector’s & PDMR dealings
31st Mar 20239:20 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSNotice of Interim Dividend
15th Mar 20233:44 pmRNSDirector/PDMR Shareholding
15th Mar 20233:41 pmRNSDirector/PDMR Shareholding
15th Mar 202310:29 amRNSDirector/PDMR Shareholding
15th Mar 20238:39 amRNSAnnual Financial Report
14th Mar 202312:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:23 amRNSHolding(s) in Company
1st Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20238:59 amRNSCompany Secretary Change
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
27th Feb 20234:56 pmRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSPreliminary Results
16th Feb 202311:38 amRNSHolding(s) in Company
8th Feb 202310:07 amRNSHolding(s) in Company
1st Feb 20239:40 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSAcquisition
16th Jan 20237:00 amRNSNotice of Preliminary Results
5th Jan 20237:00 amRNSDividend Declaration
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
15th Dec 20229:56 amEQSProactive Research Analyst Manos Halicioglu looks at Primary Health Properties
12th Dec 20227:00 amRNSSuccession Planning
6th Dec 20223:10 pmRNSHolding(s) in Company
30th Nov 202211:55 amRNSDirector/PDMR Shareholding
25th Nov 20222:19 pmRNSHolding(s) in Company
10th Nov 202210:30 amRNSDirector/PDMR Shareholding
7th Nov 202211:07 amRNSAppointment of joint broker
21st Oct 202212:01 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
20th Oct 20224:39 pmRNSHolding(s) in Company
13th Oct 20225:00 pmRNSConvertible Bond Adjustment
6th Oct 20227:00 amRNSDividend Declaration
27th Sep 20227:00 amRNSValue Creation Award Win
14th Sep 20225:36 pmRNSDirector/PDMR Shareholding
14th Sep 20225:33 pmRNSDirector/PDMR Shareholding
12th Sep 202212:06 pmRNSDirector Declaration
22nd Aug 20222:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.